GLORIA KIM: Open Payments
NPI 1366956278 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 96 payments from 13 companies in 2025. Trend: 2023 $1,789 · 2024 $1,720 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 10 | $227 |
| Alkermes, Inc. | 9 | $214 |
| Collegium Pharmaceutical, Inc. | 10 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $181 |
| ABBVIE INC. | 14 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $171 |
| Neurocrine BioSciences, Inc. | 7 | $160 |
| Otsuka America Pharmaceutical, Inc. | 7 | $136 |
| Supernus Pharmaceuticals, Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
Products named: REXULTI, ARISTADA, Jornay PM, CAPLYTA, VRAYLAR, TRINTELLIX, INGREZZA, Qelbree.
Industry payments across VA — which companies pay providers there.
